how is minimal residual disease (mrd) testing used in myeloma care?
Published 3 years ago • 27 plays • Length 1:36Download video MP4
Download video MP3
Similar videos
-
3:06
what is minimal residual testing in multiple myeloma?
-
4:10
how does minimal residual disease (mrd) testing affect treatment decisions?
-
1:31:33
measuring my myeloma with mrd testing: what is my disease state?
-
2:28
what is minimal residual disease (mrd) and how can it help speed up new myeloma drug approvals?
-
3:26
how valuable is minimal residual disease testing for myeloma patients?
-
5:46
what is minimal residual disease (mrd) in myeloma?
-
5:49
is minimal residual disease (mrd) testing routinely recommended?
-
19:41
multiple myeloma: minimal residual disease
-
3:44
what is mrd, or minimal residual disease?
-
4:10
where does mrd belong as a tool in myeloma?
-
3:21
is there a new highly sensitive blood test to detect minimal residual disease?
-
4:44
minimal residual disease (mrd) | high impact topic (hit)
-
1:29:15
webinar | patient and haematologist perspectives on minimal residual disease testing in myeloma
-
4:35
learn about measurable residual disease (mrd)
-
3:19
what impact have new minimal residual disease (mrd) assessment techniques had in myeloma?
-
48:03
minimal residual disease (mrd) in myeloma and related diseases
-
5:10
how is minimal residual disease (mrd) measured?
-
5:05
should minimal residual disease (mrd) testing be routinely performed?
-
48:14
faqs on minimal residual disease